Literature DB >> 19083010

Vagal nerve stimulator implantation: the otolaryngologist's perspective.

R Pratap1, A Farboud, H Patel, P Montgomery.   

Abstract

Vagal nerve stimulation (VNS) is a recognised and effective measure in treating refractory epilepsy and depression. VNS implantation is a widely accepted surgical procedure, most commonly performed by neurosurgeons. Otolaryngologists, in particular those with an interest in head and neck surgery, are very familiar with the surgical anatomy and dissection of the vagus nerve in the carotid sheath. We present a retrospective analysis of the first 12 patients to be implanted in our department. Our series suggests that otolaryngologists can safely and effectively perform VNS implantation. Otolaryngologists can assess and treat the most common post-operative complication of dysphonia and help the neurologist set the correct level of stimulation in such a way as to minimise laryngeal complications.

Entities:  

Mesh:

Year:  2008        PMID: 19083010     DOI: 10.1007/s00405-008-0887-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  10 in total

Review 1.  Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation.

Authors:  P Rutecki
Journal:  Epilepsia       Date:  1990       Impact factor: 5.864

2.  Vagal nerve stimulator implantation: an otolaryngologist's perspective.

Authors:  Tamer Ghanem; Stephen V Early
Journal:  Otolaryngol Head Neck Surg       Date:  2006-07       Impact factor: 3.497

3.  Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results.

Authors:  J K Penry; J C Dean
Journal:  Epilepsia       Date:  1990       Impact factor: 5.864

4.  J.L. Corning and vagal nerve stimulation for seizures in the 1880s.

Authors:  Douglas J Lanska
Journal:  Neurology       Date:  2002-02-12       Impact factor: 9.910

5.  Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy.

Authors:  Francesco Marrosu; Alessandra Serra; Alberto Maleci; Monica Puligheddu; Giovanni Biggio; Mario Piga
Journal:  Epilepsy Res       Date:  2003 Jun-Jul       Impact factor: 3.045

6.  Long-term outcome of vagus nerve stimulation therapy in patients with refractory epilepsy.

Authors:  Abuhuziefa Abubakr; Ilse Wambacq
Journal:  J Clin Neurosci       Date:  2008-02       Impact factor: 1.961

7.  Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study.

Authors:  Veerle De Herdt; Paul Boon; Berten Ceulemans; Henri Hauman; Lieven Lagae; Benjamin Legros; Bernard Sadzot; Patrick Van Bogaert; Kenou van Rijckevorsel; Helene Verhelst; Kristl Vonck
Journal:  Eur J Paediatr Neurol       Date:  2007-03-28       Impact factor: 3.140

8.  Laryngopharyngeal dysfunction from the implant vagal nerve stimulator.

Authors:  Craig Zalvan; Lucian Sulica; Steven Wolf; Jeffrey Cohen; Omar Gonzalez-Yanes; Andrew Blitzer
Journal:  Laryngoscope       Date:  2003-02       Impact factor: 3.325

9.  Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation.

Authors:  S E Krahl; K B Clark; D C Smith; R A Browning
Journal:  Epilepsia       Date:  1998-07       Impact factor: 5.864

10.  Vagus nerve stimulation for medically refractory epilepsy: a long-term follow-up study.

Authors:  J J Ardesch; H P J Buschman; L J J C Wagener-Schimmel; H E van der Aa; G Hageman
Journal:  Seizure       Date:  2007-05-31       Impact factor: 3.184

  10 in total
  2 in total

1.  The role of laryngeal electromyography in vagus nerve stimulation-related vocal fold dysmotility.

Authors:  Alberto M Saibene; Elena Zambrelli; Carlotta Pipolo; Alberto Maccari; Giovanni Felisati; Elena Felisati; Francesca Furia; Aglaia Vignoli; Maria Paola Canevini; Enrico Alfonsi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-13       Impact factor: 2.503

2.  Morphological and functional asymmetry of the human recurrent laryngeal nerve.

Authors:  J M Prades; M D Dubois; J M Dumollard; L Tordella; J Rigail; A P Timoshenko; M Peoc'h
Journal:  Surg Radiol Anat       Date:  2012-07-11       Impact factor: 1.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.